TPH1 and metabolic dysfunction-associated steatotic liver disease: These data establish a role for mast cells in regulating adipose tissue thermogenesis and suggest that the therapeutic targeting of mast cell Tph1 may be a future strategy for the treatment of obesity and related metabolic disorders including insulin resistance and NAFLD.